Financials
Income statement
| Fiscal date | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 13.6M | 13.9M | 13.7M | 12.9M |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 5.5M | 5.7M | 5.6M | 5.6M |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 3.2M | 3.3M | 3.0M | 2.4M |
| Tax provision | 688K | 727K | 662K | 511K |
| Net income | 2.5M | 2.6M | 2.4M | 1.9M |
| Basic EPS | 0.2 | 0.2 | 0.2 | 0.2 |
| Diluted EPS | 0.2 | 0.2 | 0.2 | 0.2 |
| Basic average shares | 11.8M | 11.8M | 11.8M | 11.7M |
| Diluted average shares | 11.8M | 11.8M | 11.8M | 11.7M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |